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Introduction. Rehospitalization early postekidney transplant is common and has a
negative impact in morbidity, graft survival, and health costs. Infection is one the most
common causes, and identifying the risk factors for early readmission due to infectious
complications may guide a preventive program and improve outcome. The aim of this study
was to evaluate the incidence, characterize the population, and identify the risk factors
associated with early readmission for infectious complications postekidney transplantation.
Methods. We performed a retrospective cohort study of all the kidney transplants per-
formed during 2015. The primary outcome was readmission in the first 3 months post-
transplant due to infectious causes defined by clinical and laboratory parameters.
Results. We evaluated 141 kidney transplants; 71% of subjects were men, with an overall
mean age of 50.8  15.4 years. Prior to transplant, 98% of the patients were dialysis
dependent and 2% underwent pre-emptive living donor kidney transplant. The global
readmission rate was 49%, of which 65% were for infectious complications. The most
frequent infection was urinary tract infection (n ¼ 28, 62%) and the most common
agent detected by blood and urine cultures was Klebsiella pneumonia (n ¼ 18, 40%).
The risk factors significantly associated with readmission were higher body mass index
(P ¼ .03), diabetes mellitus (P ¼ .02), older donor (P ¼ .007), and longer cold ischemia
time (P ¼ .04). There were 3 graft losses, but none due to infectious complications.
Conclusion. There was a high incidence of early rehospitalization due to infectious
complications, especially urinary tract infections to nosocomial agents. The risk factors
identified were similar to other series.*Address correspondence to Praceta Prof. Mota Pinto, 3000-
075 Coimbra, Portugal. E-mail: helenasofiapinto@gmail.comHOSPITAL readmission in early post kidney transplant(KT) period is frequent and nearly one-third of KT
recipients are rehospitalized within 30 days of discharge
[1,2]. Early rehospitalization (ERH) is associated with
increased morbidity, transition-of-care errors, and costs
both to patients and the health care system [3,4]. One of the
most common causes for ERH is infection, and KT
recipients have a cumulative incidence of infections of over
75% in the first year [3,5,6]. The high incidence of infection
is multifactorial and related in part to the surgical proced-
ure, immunosuppressive drugs, exposure to nosocomial
pathogens, and necessity for devices such as urinary cathe-
ters and intravascular lines [7].vier Inc. All rights reserved.
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surgical techniques, infectious complications remain a major
cause ofmorbidity, and these complications, especially urinary
tract infection (UTI), have been associated with increased risk
for graft rejection and general worst graft outcome [1,7,8].
The aims of this study were to evaluate the incidence of
infectious complications in the first 3 months post-KT,
characterize the population- and transplant-elated vari-
ables, and identify risk factors associated with ERH.0041-1345/17
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Table 1. Epidemiology and Risk Factors for Rehospitalization






Age (y) 52.2  18 49.4  13.4 NS
Gender, female (n) 19 22 NS
Body mass index (kg/m2) 26.3  3.8 24.4  3.7 .02
Dialysis duration (mo) 44.9  23 43.8  29 NS
Diabetes mellitus, yes (n) 11 6 .03
Urological pathology, yes (n) 12 13 NS
Transplant characteristics
Donor age (y) 56.5  8.7 51.2  11.3 .007
Living donor, yes (n) 2 5 NS
Retransplant, yes (n) 5 6 NS
HLA mismatches (mean) 3.0  1.2 3.2  1.1 NS




Urinary catheterization (d) 6.5  3.2 6.1  2.1 NS
Delayed graft function (n) 7 8 NS
Abbreviation: NS, not significant.
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DowPatients and Methods
We performed a retrospective, single-center cohort study of
all the 141 KTs performed during 2015 in our center.
Follow-up was until March 2016, which included a post-
transplant time range of 3 to 15 months.
All patients were followed up according to our center sur-
veillance protocol: medical and nurse visit twice a week for the
first month and once a week at the second and third months
post-transplant. At every visit, blood tests for graft function,
urinalysis, and hemogram are obtained. At the end of the third
month, cytomegalovirus (CMV), Epstein-Barr virus, and
donor-specific antibodies are searched in every patient. If
dysfunction occurs during the time of follow-up, patients
receive blood tests for CMV, Epstein bar virus, and donor-
specific antibodies and Doppler ultrasound. If an infection is
suspected, blood and urinary cultures are performed.
The primary outcome was hospital readmission due to
infectious causes in the first 3 months post-transplant. The
diagnosis of infection was defined based on clinical features
at presentation, laboratory parameters (positive biological
fluid cultures, CMV detection by viral proteins or isolation
of the virus in the blood, C-reaction protein levels, pro-
calcitonin, and leukocytes), and radiology exams. De-
mographic and baseline characteristics of the study
population including donor, recipient, and transplant-
related variables were abstracted from patient records.
Data were analyzed using SPSS statistics software version
15 Windows (SPSS, Inc, Chicago, Ill, USA). Comparisons
used the c2 test for categorical variables and Student t test
or the Mann-Whitney U test for continuous variables, as
appropriate. To measure odds ratios of categorical data and
their significance, we used the cross-tabs method with risk
estimation; for continuous variables, we used binary
regression. All tests were 2 tailed; P < .05 was considered
significant.
RESULTS
Demographic and Transplant Characteristics of the Study
Population
We evaluated 141 KTs during the study period, including
71% (n ¼ 100) male recipients, 96% (n ¼ 135) Caucasians,
with an overall mean age of 50.8  15.4 years. Prior to
transplant, 98% of the patients performed dialysis (79%
hemodialysis and 19% peritoneal dialysis) with a mean
length of time of dialysis of 44.6  28.9 months, and 3 pa-
tients (2%) underwent pre-emptive living donor KT. It was
the first transplant in 92% of the patients (n ¼ 130), and
95% (n ¼ 134) received a cadaveric graft. Regarding
immunosuppression, induction with basiliximab was per-
formed in 84% of the recipients (n ¼ 118), and maintenance
therapy with calcineurin inhibitors was used in 94%
patients (n ¼ 133).
Readmission Rate and Infection
Overall, 69 patients were readmitted in the first 3 months
post-transplant, representing a readmission rate of 49%.nloaded for Anonymous User (n/a) at CONSORTIUM OF PORTUGAL-Centro Hosp
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or more readmissions. Infection was the main cause for
ERH, affecting 45 patients (45/69, 65%), followed by
graft dysfunction (13/69, 19%) and surgical complications
(11/69, 16%).
The main site of infection was the urinary tract (n ¼ 28),
followed by surgery-related infections (n ¼ 8), infection of
the dialysis access (n ¼ 3), respiratory tract infection
(n ¼ 2), gastrointestinal infection (n ¼ 2), and CMV
infection (n ¼ 2). Klebsiella pneumoniae was the most
frequently isolated micro-organism (n ¼ 18), followed by
Pseudomonas aeruginosa (n ¼ 5), Escherichia coli (n ¼ 3),
and Enterococcus faecium (n ¼ 2). In one patient with
respiratory tract infection, Aspergillus fumigatus was iso-
lated. In 14 patients, no agent was isolated. The mean
duration of antimicrobial therapy was 12.5  7 days.
Predictors of Early Rehospitalization Due to Infectious
Complications
The risk factors that were significantly associated with read-
mission for infectious causes in the first 3 months post-
transplant were higher body mass index (26.3 vs 24.4, P ¼ .03;
odds ratio [OR]¼ 1.254, 95%confidence interval [1.09e1.348],
P < .05), the presence of diabetes mellitus (DM) (OR ¼ 3.27
[1.1e9.6], P < .05), older donor (56.5 vs 51.2, P ¼ .007,
OR ¼ 1.03 per year [1.02e1.063], P < .05), and longer cold
ischemia time (19.0 vs 16.9; P ¼ .04, OR ¼ 1.7 per hour
[1.04e2.67], P < .05; Table 1).
Follow-up
Time of follow-up varied between 3 and 15 months, and no
graft lost or death was registered. The mean value of serum
creatinine at follow-up was 1.65  0.42 mg/dL.italar e Universitário de Coimbra from ClinicalKey.com by Elsevier on June 08, 2018.
 Copyright ©2018. Elsevier Inc. All rights reserved.
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DowDISCUSSION
Readmission in early post-KT period is frequent, and studies
report frequencies of up to 40% in the first year, with higher
rates in the first 6 months [1,2,9]. Our primary outcome was
defined at 3months post-KT because, in our center, this is the
period considered of higher risk for early complications and
patients have more frequent hospital visits.
In our study, the global rate of EHR was 49%, and the
main causes for readmission were infection, graft dysfunc-
tion, and surgical complications, which is similar to data
present in the literature [3]. Of all the above, infectious
complications were the most frequent reason for HER,
representing 65% (n ¼ 45) of all the readmissions and 32%
in the general study population. This tendency of increased
infectious events over surgical complications and graft
dysfunction has being noticed in the past years [5,6]. Ad-
vances in immunosuppression have led to more effective
drugs that reduce the rate of acute rejection and conse-
quently graft dysfunction but with the downside of increased
infection risk [10,11]. The lower incidence of surgical com-
plications may be partly due to improvements in surgical
transplant techniques [7]. Despite that, in our sample,
8 patients had concomitant infection and surgical compli-
cations, a common feature in KT [12].
The main cause of infection in our study was UTI (62%),
consistent with literature data [13]. The higher susceptibility
of UTI in KT recipients is multifactorial: they underwent a
urological surgical procedure, present an immunosup-
pressed status, and have higher contact with nosocomial
pathogens and invasive devices such as intravascular lines
and urinary catheters [7].
There is controversy regarding urinary catheter removal:
on the one hand, it is needed for maintaining urine drainage
and to prevent of early obstruction, urinary leaks, and
vesical fistulas and to better monitor diuresis [14]; on the
other hand, it has been demonstrated that the duration of
urethral catheterization is one of the most important risk
factor for UTI, and advantages of early removal of the
catheter have been emphasized [15]. The same controversy
is present regarding double J ureteric stents: they decrease
fistulas, hematuria, and stenosis rates but increase infection
risk [16]. In our center, the mean time for urinary cathe-
terization is 6.3  2.7 days, and there was no significant
difference between groups (Table 1).
The main risk factors for EHR due to infection identified
in our study were higher body mass index, the presence of
DM, older donor, and longer cold ischemia time. Obese
recipients have higher rates of prolonged length of hospital
stay, wound dehiscence, and de novo post-transplant DM,
and all of these factors are related to increased risk of
infection [17]. DM is associated with earlier readmission in
several studies due to various causes, including infection
[5,18]. Patients with DM are more likely to have several
other comorbidities, making them a highly vulnerable
patient population. Patients who receive grafts from
extended criteria donors have significant greater risk ofnloaded for Anonymous User (n/a) at CONSORTIUM OF PORTUGAL-Centro Hosp
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and receptor, regarding the paradigm of old-for-old trans-
plantation. Longer cold ischemia time triggers a cascade of
noxious effects that increase inflammatory and immune
responses that potentially result in worst graft and patient
outcomes [20]. The exacerbated immune-inflammatory
response in patients with longer cold ischemia time may
induce the rescue of inflammatory cells, increasing the risk
of infection in KT recipients [10].
Unplanned readmissions in early post-KT is associated
with worse short- and long-term clinical outcomes, especially
frequent rehospitalizations [4]. Although our study presented
a short follow-up, no graft or patient loss was registered.
CONCLUSION
In our study, readmission in the first 3 months post-
transplant due to infectious complications occurred in
32% of the recipients, and the risk factors were higher body
mass index, the presence of DM, older donor, and longer
cold ischemia time. Recognizing modifiable risk factors is of
major importance regarding graft and patient outcome. KT
transplant guidelines already take into account the preven-
tion of the most common infections in the early post-KT
period, including the prophylaxis of CMV infection and
Pneumocystis carinii [21]. Patients identified as vulnerable
from ERH due to infection may benefit from additional or
different forms of monitoring and antibiotic therapy
management.
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